Current role
Biotechnology · Healthcare
Board Member
2023-11-01–present
Kristen Hege, M.D.
Board Member
Adaptimmune Therapeutics PLC (ADAPY)Equibles does not estimate personal net worth.
About Kristen Hege, M.D.
Kristen Hege, M.D. is recorded as Board Member at Adaptimmune Therapeutics PLC (ADAPY) since November 1, 2023. Adaptimmune Therapeutics PLC reported in an 8-K filed February 16, 2023 that Kristen Hege, M.D. was appointed independent Non-Executive Director, effective November 1, 2023. Adaptimmune Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adaptimmune Therapeutics PLC includes Adrian Rawcliffe (CEO and Board Member), David M. Mott (Chairman), Christopher Hill (CFO) and 7 others.
“Kristen Hege, M.D., has been appointed to its Board of Directors (the "Board"), as an independent Non-Executive Director, and Tal Zaks, M.D., Ph.D., will be resigning from the Board.”
Affiliation history
-
Current
2023-11-01–present
Company network
Leadership on record at Adaptimmune Therapeutics PLC
- Adrian Rawcliffe CEO, Board Member
- David M. Mott Chairman
- Christopher Hill CFO
- William Bertrand COO
- Ali Behbahani Board Member
- Andrew Allen Board Member
- Andrew Allen, MD, PhD Board Member
- Andrew R. Allen Board Member
- Dr Priti Hegde Board Member
- Garry E. Menzel Board Member